Do ACE‐inhibitors suppress tumour necrosis factor‐α production in advanced chronic renal failure?
- 1 November 1999
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 246 (5) , 503-507
Abstract
Stenvinkel P, Andersson P, Wang T, Lindholm B, Bergström J, Palmblad J, Heimbürger O, Cederholm T (Huddinge University Hospital and Karolinska Institute, Stockholm; Sweden). Do ACE‐inhibitors suppress tumour necrosis factor‐α production in advanced chronic renal failure? J Intern Med 1999; 246: 503–507.Objectives. The serum levels of the catabolic cytokine TNF‐α are often raised in malnourished chronic heart failure patients as well as in chronic renal failure (CRF) patients. Angiotensin‐converting enzyme (ACE) inhibitors are often used in these patients and may decrease TNF‐α and IL‐1β levels in vitro and in vivo. The aim of this study was to find out whether CRF patients with ongoing ACE‐inhibitor treatment have lower TNF‐α levels.Design. Cross‐sectional study.Setting. Tertiary Referral Center and University Hospital.Subjects. Ninety‐six predialysis patients (mean age 52 ± 1 years) with advanced CRF (glomerular filtration rate 7 ± 1 mL min–1).Main outcome measures. Plasma levels of TNF‐α, subjective global assessment of nutritional status and data on ongoing antihypertensive treatment (ACE‐inhibitors, beta blockers, calcium channel blockers and angiotensin II (AII) receptor blockers).Results. Patients treated with ACE‐inhibitors (n = 44) had significantly lower plasma TNF‐α levels (18.5 ± 1.2 vs. 26.6 ± 2.2 pg mL–1; P < 0.01) and were less frequently malnourished, relative to 52 patients not treated with ACE‐inhibitors. No significant difference in TNF‐α levels were observed when comparing patients with or without treatment with beta, calcium channel, or AII receptor blockers, respectively.Conclusions. The present data suggest that the use of ACE‐inhibitors is associated with lower plasma TNF‐α and CRP levels as well as a lower prevalence of malnutrition in patients with advanced CRF. Further studies are needed to establish if there is a casual relationship between these findings and, if so, the molecular mechanism(s).Keywords
This publication has 19 references indexed in Scilit:
- Malnutrition, cardiac disease, and mortality: An integrated point of viewAmerican Journal of Kidney Diseases, 1998
- Anorexigen (TNF-&agr; cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parametersNephrology Dialysis Transplantation, 1998
- Enhanced generation of interleukins 1 beta and 6 may contribute to the cachexia of chronic diseaseThe American Journal of Clinical Nutrition, 1997
- Tumor Necrosis Factor-Alpha Levels and Weight Loss in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1994
- Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patientsKidney International, 1994
- Increased Production of Tumor Necrosis Factor Activity by Hemodialysis but Not Peritoneal Dialysis PatientsNephron, 1994
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- Tumour necrosis factor alpha in severe congestive cardiac failure.Heart, 1993
- Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart FailureNew England Journal of Medicine, 1990
- Interleukin-1 Activation and Acute Phase Response during Hemodialysis1988